Risperdal - Male Breast Development
Young men and their families across the United States are filing Risperdal lawsuits as a result of developing breasts after taking the medication, a condition known as Gynecomastia. Risperdal is manufactured by Janseen Pharmaceuticals, a Johnson & Johnson company. Risperdal is an antipsychotic drug that is administered to teenage boys to treat symptoms of schizophrenia, bipolar disorders, and autism.
A large number of teenage boys have developed Gynecomastia as a result of taking Risperdal. Gynecomastia is a condition that causes breast tissue to enlarge. The U.S. Food and Drug Administration (FDA) has issued warnings to the public regarding the harmful effects of Risperdal. Further, the FDA did not approve Risperdal as safe or effective for children until 2006.
There have been lawsuits against Johnson & Johnson filed by and on behalf of teenage boys who used Risperdal. These lawsuits claim Johnson & Johnson failed to provide adequate warnings about the risks of using the product. The most frequent complications noted include:
- Production of Prolactin
- Nipple Discharge
- Pituitary Tumors
Johnson & Johnson has been ordered to pay large settlements to claimants regarding the side effects of Risperdal, and it agreed to pay $2.2 billion in criminal and civil fines to settle allegations that it improperly marketed Risperdal for unapproved uses and paid “kickbacks” to doctors and nursing homes to administer the drugs to their patients.
Male Development of Breast Tissue from Risperdal? Contact a Kansas City Lawyer
If you or someone you know has developed adverse medical conditions from taking Risperdal, you may be entitled to damages for your conditions. Wendt Law Firm P.C. specializes in helping injured people protect their rights against big companies who produce dangerous medication. Call us to talk about how we can help you seek the justice and compensation you deserve.